These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3260969

  • 1. [Serial changes in protein C, antithrombin III, alpha 2-plasmin inhibitor, plasminogen and von Willebrand factor during the course of disseminated intravascular coagulation (DIC)].
    Takahashi H, Hanano M, Takizawa S, Tatewaki W, Fuse I, Satoh K, Wada K, Shibata A.
    Rinsho Ketsueki; 1988 Mar; 29(3):336-43. PubMed ID: 3260969
    [No Abstract] [Full Text] [Related]

  • 2. [Changes in protein C inhibitor in disseminated intravascular coagulation: relationship with heparin cofactor II and alpha 2-plasmin inhibitor].
    Kazama Y, Takahashi K, Oguma Y, Sakuragawa N.
    Rinsho Ketsueki; 1988 Mar; 29(3):344-8. PubMed ID: 3398266
    [No Abstract] [Full Text] [Related]

  • 3. Hemostatic variation during perioperative period of orthotopic liver transplantation without venovenous bypass.
    Wang Y, Liu Y, Han R, Zhu Z, Zhang Y, Wang X, Wang L, Shen Z.
    Thromb Res; 2008 Mar; 122(2):161-6. PubMed ID: 18048090
    [Abstract] [Full Text] [Related]

  • 4. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF, Toh CH, Hoogendoorn H, Manuel RP, Nesheim ME, Solymoss S, Giles AR.
    Thromb Haemost; 1993 May 03; 69(5):448-53. PubMed ID: 7686692
    [Abstract] [Full Text] [Related]

  • 5. [Levels of antithrombin III and alpha 2-plasmin inhibitor in bone marrow aspirate].
    Tsurumi N, Hayashi H, Ishimaru F, Fujita T, Takai Y, Tsuda T, Kimura I.
    Rinsho Ketsueki; 1988 Aug 03; 29(8):1207-13. PubMed ID: 3204671
    [No Abstract] [Full Text] [Related]

  • 6. Depressed plasma activity of plasminogen or alpha2 plasmin inhibitor is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation.
    Asakura H, Ontachi Y, Mizutani T, Kato M, Ito T, Saito M, Morishita E, Yamazaki M, Suga Y, Miyamoto KI, Nakao S.
    Blood Coagul Fibrinolysis; 2001 Jun 03; 12(4):275-81. PubMed ID: 11460011
    [Abstract] [Full Text] [Related]

  • 7. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.
    Minamikawa K, Wada H, Wakita Y, Ohiwa M, Tanigawa M, Deguchi K, Hiraoka N, Huzioka H, Nishioka J, Hayashi T.
    Thromb Haemost; 1994 Feb 03; 71(2):192-4. PubMed ID: 7514816
    [Abstract] [Full Text] [Related]

  • 8. [Protein C levels in childhood disseminated intravascular coagulation].
    Hanada T.
    Rinsho Ketsueki; 1988 Feb 03; 29(2):156-60. PubMed ID: 3385942
    [No Abstract] [Full Text] [Related]

  • 9. [Significance of the activity of indicators of the fibrinolytic system on assessment of the hemostatic state].
    Savchuk OM, Hamisoniia MSh, Kizim OI, Platonova TM.
    Fiziol Zh (1994); 2001 Feb 03; 47(3):58-63. PubMed ID: 11519252
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H, Mori Y, Okabayashi K, Gabazza EC, Kushiya F, Watanabe M, Nishikawa M, Shiku H, Nobori T.
    Am J Hematol; 2003 Jan 03; 72(1):1-7. PubMed ID: 12508260
    [Abstract] [Full Text] [Related]

  • 12. [A dynamic study of plasminogen, antithrombin III, fibrinogen and DIC in epidemic hemorrhagic fever].
    Xiang LB, Zhang ZY, Chen JM.
    Zhonghua Nei Ke Za Zhi; 1988 Dec 03; 27(12):743-6, 782. PubMed ID: 2907875
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
    Dickneite G, Czech J, Keuper H.
    Circ Shock; 1994 Apr 03; 42(4):183-9. PubMed ID: 8055664
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Enhanced ex vivo proteolysis of plasma von Willebrand factor in disseminated intravascular coagulation.
    Takahashi H, Tatewaki W, Wada K, Niwano H, Shibata A.
    Blood Coagul Fibrinolysis; 1992 Oct 03; 3(5):583-8. PubMed ID: 1450324
    [Abstract] [Full Text] [Related]

  • 19. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K.
    Rinsho Byori; 1994 Jan 03; 42(1):45-55. PubMed ID: 8107283
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.